×
About 205,326 results

ALLMedicine™ Hepatitis Center

Research & Reviews  99,131 results

Prognostic, clinical and therapeutic importance of RANTES-CCR5 axis in hepatitis A infe...
https://doi.org/10.1002/jmv.26557
Journal of Medical Virology; Baruah V, Tiwari D et. al.

Sep 25th, 2020 - Fulminant hepatic failure (FHF) is a lethal manifestation of hepatitis A virus (HAV) infection, whose underlying mechanisms are poorly understood. We aimed to evaluate the importance of the modulation of RANTES-CCR5 signalling axis and its immunom...

Hepatitis B in the Northern Territory: insights into the changing epidemiology of an an...
https://doi.org/10.1111/imj.15069
Internal Medicine Journal; Qama A, Allard N et. al.

Sep 25th, 2020 - Aboriginal and Torres Strait Islander people are disproportionately affected by hepatitis B virus (HBV) infection. A proposed mismatch between standard vaccines and the HBV/C4 sub-genotype prevalent in Aboriginal people in the Northern Territory (...

Secondary prevention for hepatocellular carcinoma in patients with chronic hepatitis B:...
https://doi.org/10.1007/s00535-020-01726-3
Journal of Gastroenterology; Yip TC, Lai JC et. al.

Sep 25th, 2020 - Reducing the incidence of hepatocellular carcinoma (HCC) in patients with chronic hepatitis B (CHB) is the key ultimate goal set in essentially all treatment guidelines. There has been solid evidence supporting the relationship between serum hepat...

Risky injection practices and HCV awareness in Chiang Mai Province, Thailand: a respond...
https://doi.org/10.1186/s12889-020-09549-w
BMC Public Health; Prouté M, Le Coeur S et. al.

Sep 25th, 2020 - People who inject drugs (PWID) are the most exposed to hepatitis C virus (HCV). In Thailand, drug use is highly criminalized, and harm reduction services are scarce. This study estimates risky injection practices and assesses the proportion of HCV...

Beyond clinical outcomes: the social and healthcare system implications of hepatitis C ...
https://doi.org/10.1186/s12879-020-05426-4
BMC Infectious Diseases; Torrens M, Soyemi T et. al.

Sep 25th, 2020 - Hepatitis C virus (HCV) infections in people who inject drugs (PWID) can now be treated and cured. However, the impact that HCV treatment has on drug-user health, practices and wellbeing is not known. The aim of this research was to understand the...

see more →

Guidelines  311 results

EASL recommendations on treatment of hepatitis C - Final update of the series.
https://doi.org/10.1016/j.jhep.2020.08.018
Journal of Hepatology;

Sep 21st, 2020 - Hepatitis C virus (HCV) infection is a major cause of chronic liver disease, with approximately 71 million chronically infected individuals worldwide. Clinical care for patients with HCV-related liver disease has advanced considerably thanks to an...

Hepatitis B Virus Screening and Management for Patients With Cancer Prior to Therapy: ASCO Provisional Clinical Opinion Update
https://ascopubs.org/doi/full/10.1200/JCO.20.01757
Journal of Clinical Oncology; Hwang JP

Jul 26th, 2020 - This Provisional Clinical Opinion update presents a clinically pragmatic approach to hepatitis B virus (HBV) screening and management.

Expert Perspective on ASCO20 Gastrointestinal Cancers Research
https://dailynews.ascopubs.org/do/10.1200/ADN.20.200231/full/

Jul 1st, 2020 - Donafenib, a deuterated derivative of sorafenib, was tested against sorafenib in the frontline setting in hepatitis B– associated hepatocellular carcinoma (HCC) in a large, multi-institutional study in China (Abstract 4506).

Licensure of a Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poli...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004397
MMWR. Morbidity and Mortality Weekly Report; Oliver SE, Moore KL

Feb 6th, 2020 - On December 21, 2018 the Food and Drug Administration (FDA) licensed a hexavalent combined diphtheria and tetanus toxoids and acellular pertussis (DTaP) adsorbed, inactivated poliovirus (IPV), Haemophilus influenzae type b (Hib) conjugate (meningo...

Opioid Use Disorder: Medical Treatment Options
https://www.aafp.org/afp/2019/1001/p416.html
American Family Physician; Coffa,D.,et al

Sep 30th, 2019 - Opioid use disorder is highly prevalent and can be fatal. At least 2.1 million Americans 12 years and older had opioid use disorder in 2016, and approximately 47,000 Americans died from opioid overdoses in 2017. Opioid use disorder is a chronic re...

see more →

Drugs  351 results see all →

Clinicaltrials.gov  101,503 results

Prognostic, clinical and therapeutic importance of RANTES-CCR5 axis in hepatitis A infe...
https://doi.org/10.1002/jmv.26557
Journal of Medical Virology; Baruah V, Tiwari D et. al.

Sep 25th, 2020 - Fulminant hepatic failure (FHF) is a lethal manifestation of hepatitis A virus (HAV) infection, whose underlying mechanisms are poorly understood. We aimed to evaluate the importance of the modulation of RANTES-CCR5 signalling axis and its immunom...

Hepatitis B in the Northern Territory: insights into the changing epidemiology of an an...
https://doi.org/10.1111/imj.15069
Internal Medicine Journal; Qama A, Allard N et. al.

Sep 25th, 2020 - Aboriginal and Torres Strait Islander people are disproportionately affected by hepatitis B virus (HBV) infection. A proposed mismatch between standard vaccines and the HBV/C4 sub-genotype prevalent in Aboriginal people in the Northern Territory (...

Secondary prevention for hepatocellular carcinoma in patients with chronic hepatitis B:...
https://doi.org/10.1007/s00535-020-01726-3
Journal of Gastroenterology; Yip TC, Lai JC et. al.

Sep 25th, 2020 - Reducing the incidence of hepatocellular carcinoma (HCC) in patients with chronic hepatitis B (CHB) is the key ultimate goal set in essentially all treatment guidelines. There has been solid evidence supporting the relationship between serum hepat...

Risky injection practices and HCV awareness in Chiang Mai Province, Thailand: a respond...
https://doi.org/10.1186/s12889-020-09549-w
BMC Public Health; Prouté M, Le Coeur S et. al.

Sep 25th, 2020 - People who inject drugs (PWID) are the most exposed to hepatitis C virus (HCV). In Thailand, drug use is highly criminalized, and harm reduction services are scarce. This study estimates risky injection practices and assesses the proportion of HCV...

Beyond clinical outcomes: the social and healthcare system implications of hepatitis C ...
https://doi.org/10.1186/s12879-020-05426-4
BMC Infectious Diseases; Torrens M, Soyemi T et. al.

Sep 25th, 2020 - Hepatitis C virus (HCV) infections in people who inject drugs (PWID) can now be treated and cured. However, the impact that HCV treatment has on drug-user health, practices and wellbeing is not known. The aim of this research was to understand the...

see more →

News  3,843 results

Hepatitis B Virus Screening and Management for Patients With Cancer Prior to Therapy: ASCO Provisional Clinical Opinion Update
https://ascopubs.org/doi/full/10.1200/JCO.20.01757
Journal of Clinical Oncology; Hwang JP

Jul 26th, 2020 - This Provisional Clinical Opinion update presents a clinically pragmatic approach to hepatitis B virus (HBV) screening and management.

Expert Perspective on ASCO20 Gastrointestinal Cancers Research
https://dailynews.ascopubs.org/do/10.1200/ADN.20.200231/full/

Jul 1st, 2020 - Donafenib, a deuterated derivative of sorafenib, was tested against sorafenib in the frontline setting in hepatitis B– associated hepatocellular carcinoma (HCC) in a large, multi-institutional study in China (Abstract 4506).

Triple antiviral drug shows early promise in COVID-19 trial
https://www.reuters.com/article/us-health-coronavirus-triple-drug/triple-antiviral-drug-shows-early-promise-in-covid-19-trial-idUSKBN22K2Z9

May 8th, 2020 - LONDON (Reuters) - A triple drug combination of antiviral medicines helped relieve symptoms in patients with mild to moderate COVID-19 infection and swiftly reduced the amount of virus in their bodies, according to results of a small trial in Hong...

Will Gilead price its coronavirus drug for public good or company profit?
https://www.reuters.com/article/us-health-coronavirus-gilead-pricing/will-gilead-price-its-coronavirus-drug-for-public-good-or-company-profit-idUSKBN22I2NM

May 6th, 2020 - (Reuters) - Gilead Sciences Inc (GILD.O) faces a new dilemma in deciding how much it should profit from the only treatment so far proven to help patients infected with the novel coronavirus. FILE PHOTO: An ampule of Ebola drug Remdesivir is pictur...

AASLD: Liver transplants should proceed despite COVID-19
https://www.mdedge.com/gihepnews/article/220026/coronavirus-updates/aasld-liver-transplants-should-proceed-despite-covid-19?channel=63993
M. Alexander Otto, MDedge News

Apr 1st, 2020 - In liver transplant recipients or patients with autoimmune hepatitis on immunosuppressive therapy, acute cellular rejection or disease flare should not be presumed in the face of active coronavirus disease 2019 (COVID-19), according to the America.

see more →

Patient Education  187 results see all →